102 related articles for article (PubMed ID: 7702990)
1. New antineoplastic agents in lung cancer 1988-1993.
Grant SC; Kris MG
Cancer Treat Res; 1995; 72():323-47. PubMed ID: 7702990
[No Abstract] [Full Text] [Related]
2. New chemotherapeutic agents in non-small-cell lung cancer.
Feigal EG; Christian M; Cheson B; Grever M; Friedman MA
Semin Oncol; 1993 Apr; 20(2):185-201. PubMed ID: 7683142
[No Abstract] [Full Text] [Related]
3. Promising new agents in the treatment of non-small cell lung cancer.
Edelman MJ; Gandara DR
Cancer Chemother Pharmacol; 1996; 37(5):385-93. PubMed ID: 8599859
[TBL] [Abstract][Full Text] [Related]
4. New drug for therapy of non-small cell lung cancer.
Klastersky J
Lung Cancer; 1994 Nov; 11 Suppl 3():S139-49. PubMed ID: 7704506
[No Abstract] [Full Text] [Related]
5. [Irinotecan].
Yokoyama A
Nihon Rinsho; 2002 May; 60 Suppl 5():339-42. PubMed ID: 12101684
[No Abstract] [Full Text] [Related]
6. Extensive small-cell lung cancer: a treatment overview.
Sandler A
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):49-55. PubMed ID: 10981291
[TBL] [Abstract][Full Text] [Related]
7. [Advances in lung cancer].
Pautier P
Pathol Biol (Paris); 1992 Dec; 40(9 Pt 2):956-9. PubMed ID: 1363892
[TBL] [Abstract][Full Text] [Related]
8. [Vinorelbine for non-small cell lung cancer].
Seto T
Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
[No Abstract] [Full Text] [Related]
9. New directions for chemotherapy in non-small-cell lung cancer.
Green MR
Chest; 1993 Apr; 103(4 Suppl):370S-372S. PubMed ID: 8096453
[TBL] [Abstract][Full Text] [Related]
10. [Taxol in bronchial carcinoma].
Gatzemeier U
Med Klin (Munich); 1996 Dec; 91 Suppl 2():1-6. PubMed ID: 9082171
[No Abstract] [Full Text] [Related]
11. Lung cancer--time to move on from chemotherapy.
Carney DN
N Engl J Med; 2002 Jan; 346(2):126-8. PubMed ID: 11784881
[No Abstract] [Full Text] [Related]
12. [Role of irinotecan in the treatment of small cell carcinoma].
Crinò L
Tumori; 2001; 87(6):A35-7. PubMed ID: 11995707
[No Abstract] [Full Text] [Related]
13. Current status of irinotecan in lung cancer.
Fukuoka M
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):6-7. PubMed ID: 11221022
[TBL] [Abstract][Full Text] [Related]
14. An important new drug and regimen for non-small-cell lung Ca.
Oncology (Williston Park); 1990 Oct; 4(10):21. PubMed ID: 1963314
[No Abstract] [Full Text] [Related]
15. The Fox Chase Cancer Center and Free University Hospital Investigators' Workshop and Consensus Conference on Paclitaxel. Part 1: Lung Cancer. Puerto Rico, March 12-16, 1997.
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-1-S12-162; quiz S12-163-S12-173. PubMed ID: 9340788
[No Abstract] [Full Text] [Related]
16. New treatment agents for advanced small cell and non-small cell lung cancer.
Bunn PA; Kelly K
Semin Oncol; 1995 Jun; 22(3 Suppl 6):53-63. PubMed ID: 7597434
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
Sirotnak FM; Zakowski MF; Miller VA; Scher HI; Kris MG
Clin Cancer Res; 2000 Dec; 6(12):4885-92. PubMed ID: 11156248
[TBL] [Abstract][Full Text] [Related]
19. Future directions in therapeutic approaches for small cell lung cancer.
Bunn PA
Semin Oncol; 1996 Dec; 23(6 Suppl 16):136-8. PubMed ID: 9007141
[No Abstract] [Full Text] [Related]
20. Phase II study of PALA and PCNU in the treatment of non-small cell lung cancer (EST 2580): an Eastern Cooperative Oncology Group study.
Ettinger DS; Tritchler D; Earhart R; Creech RH
Cancer Treat Rep; 1984 Oct; 68(10):1297-8. PubMed ID: 6525602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
